Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase Study About Feeding Artery Obliteration by Chemoembolization on Survival of Patients With Unresectable Hepatocellular Carcinoma

NCT01677468 is registered in ClinicalTrials.gov with Hallym University Medical Center as lead sponsor.

NCT NCT01677468
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01677468 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase Study About Feeding Artery Obliteration by Chemoembolization on Survival of Patients With Unresectable Hepatocellular Carcinoma
Lead sponsor
Hallym University Medical Center
Phase
Not applicable
Overall status
Unknown status
Start date
August 31, 2012
Completion date
July 31, 2015
Enrollment
250 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma, transarterial chemoembolization